ライフサイエンスコーパス: atrial tachycardia

1 intraatrial reentrant tachycardia, 40% focal atrial tachycardia).

2 to induce paroxysmal atrial fibrillation or atrial tachycardia.

3 reentry, Wolff-Parkinson-White syndrome, and atrial tachycardia.

4 roxysmal atrial fibrillation, and paroxysmal atrial tachycardia.

5 dent right atrial reentry (n=7), and 1 focal atrial tachycardia.

6 Ao junction can be a frequent source of left atrial tachycardia.

7 d of ectopic activity in patients with focal atrial tachycardia.

8 as used to simulate the site of origin of an atrial tachycardia.

9 f holes to induce and analyze macroreentrant atrial tachycardia.

10 rhythmic activity consistent with multifocal atrial tachycardia.

11 atients referred for treatment of AF or left atrial tachycardia.

12 rial fibrillation, atrial flutter, and focal atrial tachycardia.

13 of this study was freedom from recurrent AF/atrial tachycardia.

14 ned as >30 seconds of AF, atrial flutter, or atrial tachycardia.

15 t ablation was performed for recurrent AF or atrial tachycardia.

16 adaptive molecular and cellular response to atrial tachycardia.

17 ), 49% of the patients remained free from AF/atrial tachycardia.

18 successful in eliminating left versus right atrial tachycardias.

19 These foci usually induce irregular atrial tachycardias.

20 aches for atrial flutters and macroreentrant atrial tachycardias.

21 in 26 (96%) of 27 (95% CI 81% to 100%) right atrial tachycardias.

22 nd this drove 30% (7/23) of our postablation atrial tachycardias.

23 nvolving the left atrium compared with right atrial tachycardias.

24 ugh low-voltage regions and aids ablation of atrial tachycardias.

25 sence of LVA (<0.5 mV) and inducible regular atrial tachycardias.

26 istent AF (81%), paroxysmal AF (9%), or left atrial tachycardia (10%) under deep sedation (53%) or ge

27 lter recordings; and (4) higher incidence of atrial tachycardia (15% versus 41%, P=0.02) and atrial f

28 Of 27 focal right atrial tachycardias, 18 (67%, 95% confidence interval [C

29 ilure (3%), liver abscesses (3%), paroxysmal atrial tachycardia (3%), thoracic pain (3%), upper gastr

30 e urosepsis (5.1%) in the ablation group and atrial tachycardia (3.9%) in the medication group.

31 Of the 40 patients with annular atrial tachycardia, 4 tachycardias were localized to the

32 s (age 49+/-16 years, 9 females) with either atrial tachycardia (6 patients) or atrial fibrillation t

33 ia, 53%) and focal atrial tachycardia (focal atrial tachycardia, 6%).

34 tory of successfully ablated incessant focal atrial tachycardia 64+/-36 months prior, and 20 healthy

35 ed by atrial fibrillation (28.8%), and focal atrial tachycardia (9.5%).

36 attributable to lead failure (14%), sinus or atrial tachycardias (9%), and/or oversensing (4%).

37 hildhood, 50% of patients develop multifocal atrial tachycardia, a treatment-resistant tachyarrhythmi

38 imilar to tachycardia cycle length; 2) focal atrial tachycardia: a P-A interval < or =-20 ms; and 3)

39 Acute procedural success of atrial tachycardia ablation in congenital heart patients

40 Patients referred for atrial tachycardia ablation underwent dense electroanato

41 ctiveness was freedom from AF/atrial flutter/atrial tachycardia absent new/increased dosage of previo

42 chronic tachycardias have been reported with atrial tachycardias, accessory pathway reciprocating tac

43 he AF substrates tested, including sustained atrial tachycardia/AF itself, enhanced post-RFA atrial t

44 The 12-month atrial tachycardias/AF-free survival was 62% for patient

45 The outcomes of freedom from AF/atrial tachycardia after 1 or several ablation procedure

46 proportion of patients with freedom from AF/atrial tachycardia after a single procedure was 49.2% (9

47 with AF and 16 patients with atrial flutter/atrial tachycardia) after the initial procedure during a

48 In a separate data set (12 atrial tachycardia and 10 ventricular tachycardia), we e

49 In 1753 atrial tachycardia and 1426 ventricular tachycardia reco

50 nd induce atrial tachyarrhythmias, including atrial tachycardia and atrial fibrillation (AF).

51 All paroxysmal atrial tachycardia and atrial fibrillation episodes were

52 The RATE Registry (Registry of Atrial Tachycardia and Atrial Fibrillation Episodes) is

53 harges that preceded the onset of paroxysmal atrial tachycardia and atrial fibrillation.

54 s linked to conditions like angina pectoris, atrial tachycardia and Meniere's disease, bimatoprost to

55 A-A-V response was observed in all cases of atrial tachycardia and simulated atrial tachycardia, eve

56 on of pre-closure ablation for patients with atrial tachycardia and suitability for closure or/and ta

57 % and 5%, respectively, also had episodes of atrial tachycardia and supraventricular tachyarrhythmia.

58 Both in atrial tachycardia and ventricular tachycardia, the vari

59 istry designed to document the prevalence of atrial tachycardia and/or fibrillation (AT/AF) of any du

60 identify the anatomic origin of focal right atrial tachycardias and to define their relation with th

61 prising atrial fibrillation, atrial flutter, atrial tachycardia, and supraventricular tachyarrhythmia

62 ntricular overdrive pacing was diagnostic of atrial tachycardia, and this maneuver could be applied t

63 nd long-term recurrence of AF/atrial flutter/atrial tachycardia are significantly lower using general

64 Post ablation atrial tachycardias are characterized by low-voltage sig

65 T to adenosine can immediately differentiate atrial tachycardia arising from a focal source from that

66 persistent atrial fibrillation (AF) and left atrial tachycardia, as stated in the last consensus stat

67 from atrial fibrillation, atrial flutter, or atrial tachycardia at 12 months.

68 ed the likelihood of remaining free of AF or atrial tachycardia at 6 and 12 months.

69 lly abnormal atrial tissue and mechanisms of atrial tachycardia (AT) after mitral valve (MV) surgery.

70 es recurrence of atrial fibrillation (AF) or atrial tachycardia (AT) after radiofrequency catheter ab

71 Sixteen patients with atrial tachycardia (AT) after SR-CHD were studied (atria

72 r radiofrequency catheter ablation (RFCA) of atrial tachycardia (AT) arising from the coronary sinus

73 Some reentrant atrial tachycardia (AT) cases are characterized by chall

74 g criteria unequivocally differentiate focal atrial tachycardia (AT) caused by microreentry, triggere

75 Regular atrial tachycardia (AT) coexisting with AF occurred in 6

76 Three atrial tachycardia (AT) episodes originated from a focus

77 The device discriminated atrial tachycardia (AT) from atrial fibrillation (AF) on

78 re TAVR: paroxysmal atrial fibrillation (AF)/atrial tachycardia (AT) in 28, advanced atrioventricular

79 eparate focal from atypical macro-re-entrant atrial tachycardia (AT) on the electrocardiogram (ECG).

80 lar fibrillation (VF) preceded by paroxysmal atrial tachycardia (AT) or atrial fibrillation (AF)-in p

81 Here, we assess the efficacy of optogenetic atrial tachycardia (AT) termination in human hearts usin

82 lternative approach to activation mapping of atrial tachycardia (AT) that avoids electrogram annotati

83 this study was to determine the mechanism of atrial tachycardia (AT) that occurs after ablation of at

84 Acute conversion to NSR or atrial tachycardia (AT) was achieved in 90% of cases.

85 he feasibility of optogenetic termination of atrial tachycardia (AT), comparing two different illumin

86 adenosine has mechanism-specific effects on atrial tachycardia (AT), such that adenosine terminates

87 atrial fibrillation (AF) or other sustained atrial tachycardia (AT), verified by monthly visits, amb

88 and mechanism of adenosine-insensitive focal atrial tachycardia (AT).

89 with symptomatic atrial fibrillation (AF) or atrial tachycardia (AT).

90 ctrophysiologic (EP) identity of left septal atrial tachycardia (AT).

91 w conduction capable of supporting reentrant atrial tachycardia (AT).

92 topic beats triggering AF or sustained focal atrial tachycardia (AT).

93 onal reciprocating tachycardia (PJRT; n=12), atrial tachycardia (AT; n=53), and inappropriate sinus t

94 wavefronts, but this is often difficult for atrial tachycardias (AT) after ablation of atrial fibril

95 activation mapping of reentrant scar-related atrial tachycardias (AT) allows efficient radiofrequency

96 Atrial tachycardias (AT) during or after ablation of atr

97 onal linear ablation lines in the setting of atrial tachycardias (AT) in patients with persistent AF

98 The role of subsequent atrial tachycardias (AT) in the context of persistent at

99 ping (ECM), in facilitating the diagnosis of atrial tachycardias (AT).

100 al tachyarrhythmia (ie, atrial fibrillation, atrial tachycardia, atrial flutter) episodes, failure to

101 Atrial tachycardia/atrial fibrillation accounted for >50

102 y of CRT loss increased, the contribution of atrial tachycardia/atrial fibrillation and SAV/PAV to th

103 Among those with suboptimal pacing, atrial tachycardia/atrial fibrillation was the most comm

104 ostics explained 55.8% of pacing loss: 30.6% atrial tachycardia/atrial fibrillation; 16.6% premature

105 ary outcome was symptomatic recurrence of AF/atrial tachycardia/atrial flutter lasting >30 seconds, d

106 (3) In 10 cases of atrial tachycardia/atrial flutter, ECM accurately identi

107 ng ablation, 82% remained AF-free and 74% AF/atrial tachycardia/atrial flutter-free during follow-up

108 cs; 74% remained AF-free and 66% remained AF/atrial tachycardia/atrial flutter-free on or off AADs (a

109 ythmias, atrial fibrillation/atrial flutter, atrial tachycardia, atrioventricular nodal reentrant tac

110 drug-induced arrhythmias (bradyarrhythmias, atrial tachycardia, atrioventricular node reentrant tach

111 Atrial tachycardias (ATs) are a significant source of mo

112 jective of this study is to describe complex atrial tachycardias (ATs) that occur after this approach

113 iled noninvasive localization of right-sided atrial tachycardia before radiofrequency catheter ablati

114 mia (atrial fibrillation, atrial flutter, or atrial tachycardia) between 91 and 365 days after cathet

115 rial tachyarrhythmia (AF, atrial flutter, or atrial tachycardia) between days 91 and 365 after ablati

116 change in right atrial pressure, persistent atrial tachycardia caused ARP and ERP to fall by > 10%.

117 flutter is characterized by a macroreentrant atrial tachycardia circuit.

118 urity of the extrastimulus and time to first atrial tachycardia complex were directly correlated (R=0

119 Ivabradine-sensitive atrial tachycardia constitutes 64% of incessant FAT in p

120 Sustained, self-limited episodes of atrial tachycardia (cycle length, 340+/-56 ms; duration,

121 responses in a large clinical macroreentrant atrial tachycardia database.

122 matic or asymptomatic AF, atrial flutter, or atrial tachycardia), detected by either scheduled or uns

123 Sustained atrial tachycardia developed in 22 of 143 patients (15%)

124 ocumented atrial fibrillation/atrial flutter/atrial tachycardia episodes >30 seconds through the 12-m

125 role in re-entry-promoting effects of short atrial tachycardia episodes, offering insights into earl

126 ll cases of atrial tachycardia and simulated atrial tachycardia, even in the presence of dual atriove

127 Most paroxysmal atrial tachycardia events (89%) were preceded by ICNA an

128 Focal atrial tachycardia (FAT) is an uncommon cause of suprave

129 Focal atrial tachycardia (FAT) is extremely difficult to map a

130 Incessant focal atrial tachycardia (FAT), if untreated, can lead to vent

131 At fast electrical rates typical of atrial tachycardia/fibrillation, spontaneous Ca(2+) rele

132 CFAE arm had a higher incidence of organized atrial tachycardia/flutter (24/33 [73%] versus 11/31 [35

133 The ICD should discriminate between atrial tachycardia/flutter (AT), which may be terminated

134 atrial reentrant tachycardia, 53%) and focal atrial tachycardia (focal atrial tachycardia, 6%).

135 The primary outcome was freedom from AF or atrial tachycardia for longer than 30 seconds after a si

136 euvers, it can be difficult to differentiate atrial tachycardia from other forms of paroxysmal suprav

137 rrence was defined as AF, atrial flutter, or atrial tachycardia >30 s on two 14-day Holters performed

138 dom from any arrhythmia (atrial fibrillation/atrial tachycardia >30 seconds) after a single ablation

139 x >85 mL/m(2) (hazard ratio, 3.25; P<0.001), atrial tachycardia (hazard ratio, 2.03; P=0.021), and ag

140 ecurrence of symptomatic AF, atrial flutter, atrial tachycardia (HR, 0.56 [95% CI, 0.33-0.95]; P = .0

141 A second patient with ALMCA had atrial tachycardia immediately after exercise, with infe

142 al AF in 48 patients (28%) and persistent AF/atrial tachycardia in 123 patients (72%).

143 lishing the mechanistic basis for multifocal atrial tachycardia in CS.

144 FAE ablation did not improve freedom from AF/atrial tachycardia in patients with paroxysmal or persis

145 prove the overall rate of freedom from AF or atrial tachycardia in patients with persistent AF (OR, 1

146 itive and specific for the identification of atrial tachycardia in the electrophysiology laboratory.

147 The most common finding was rapid, irregular atrial tachycardias in the region of the pulmonary veins

148 Right atrial tachycardias included cavotricuspid isthmus-depen

149 Left atrial tachycardias included reentry around the mitral v

150 ce had atrial arrhythmias, including AFL and atrial tachycardia, indicating that Pitx2 haploinsuffici

151 change included atrial premature complexes, atrial tachycardia, interpolated ventricular premature c

152 Atrial tachycardia is a frequent acute outcome with coil

153 Atrial tachycardia is a well-recognized long-term compli

154 Multifocal atrial tachycardia is defined by three distinct P-wavefo

155 ined as an episode of AF, atrial flutter, or atrial tachycardia lasting >30 seconds after a 3-month b

156 Arrhythmia recurrence was defined as AF or atrial tachycardia lasting >30 seconds beyond a 3-month

157 acterize the circuit of macroreentrant right atrial tachycardia (MacroAT) in patients after surgical

158 come of infants and children with multifocal atrial tachycardia (MAT).

159 Recent studies have suggested that right atrial tachycardias may also have a characteristic anato

160 Ablation of subsequent organized atrial tachycardias may be needed to maintain sinus rhyt

161 romic reciprocating tachycardia (n = 43), 3) atrial tachycardia (n = 19) and 4) atrial tachycardia si

162 ntricular tachycardia (n = 5), and undefined atrial tachycardia (n = 21).

163 n 47 cases: macroreentrant (n = 25) or focal atrial tachycardia (n = 8), atrioventricular nodal reent

164 l fibrillation (n=13), atrial flutter (n=4), atrial tachycardia (n=3), idiopathic ventricular tachyca

165 trial tachycardia (n=59, 56 patients), focal atrial tachycardia (n=33, 25 patients), ventricular ecto

166 achycardia (n=3, 2 patients), macroreentrant atrial tachycardia (n=59, 56 patients), focal atrial tac

167 A trend toward a higher incidence of left atrial tachycardia occurrence in the wide antral circumf

168 that approximately two thirds of focal right atrial tachycardias occurring in the absence of structur

169 erm procedural outcome or freedom from AF or atrial tachycardia (odds ratio [OR], 0.80; 95% confidenc

170 umented atrial arrhythmia (AF/atrial flutter/atrial tachycardia) of >=30 seconds on the basis of elec

171 ity of patients, with a high freedom from AF/atrial tachycardia off antiarrhythmic drugs at long-term

172 going STAR-guided ablation were free from AF/atrial tachycardia off antiarrhythmic drugs.

173 e, 94% of the patients remained free from AF/atrial tachycardia off antiarrhythmic drugs.

174 77 reablation group patients were free of AF/atrial tachycardia on no AADs; in contrast, in the AAD g

175 thermore, 2 of 7 ablation dogs had sustained atrial tachycardias, one of which was successfully ablat

176 ocedural success was defined as freedom from atrial tachycardia or AF in the absence of antiarrhythmi

177 Any episode of atrial tachycardia or AF lasting longer than 30 s was co

178 heart rate (HR) and is often accompanied by atrial tachycardia or atrioventricular (AV) block.

179 The 1-year freedom from atrial fibrillation, atrial tachycardia, or atrial flutter recurrence rate af

180 atrial fibrillation (P=0.046) or paroxysmal atrial tachycardia (P<0.001) episodes.

181 y 9 (12%) of the 77 patients were free of AF/atrial tachycardia (P<0.01) throughout follow-up.

182 nd 1,420 long (>10 s) episodes of paroxysmal atrial tachycardia (PAT).

183 In 3 atrial tachycardia patients, PN displacement was not pos

184 ree of target arrhythmia was achieved in all atrial tachycardia patients; however, a nontargeted vent

185 on per day and 10+/-3 episodes of paroxysmal atrial tachycardia per day in group 1.

186 F termination is associated with consecutive atrial tachycardia procedures.

187 mary outcome (freedom of atrial fibrillation/atrial tachycardia rate at 12 months follow-up) in 48.2%

188 rge real-world PFA registry, freedom from AF/atrial tachycardia recurrence after 1 year was similar i

189 mptomatic atrial fibrillation/atrial flutter/atrial tachycardia recurrence and repeat ablation was 78

190 edom from atrial fibrillation/atrial flutter/atrial tachycardia recurrence was 72.5%.

191 ar follow-up, freedom from AF/atrial flutter/atrial tachycardia recurrence was significantly higher i

192 At 1-year follow-up, freedom from AF/atrial tachycardia recurrence was similar in the ablatio

193 er rate of consecutive procedures because of atrial tachycardia recurrences (P = 0.003; HR, 1.71; 95%

194 The rate of AF/atrial tachycardia recurrences progressively increased o

195 s in mapping, many aspects of macroreentrant atrial tachycardia remain unsolved.

196 ivation pattern of localized reentry (LR) in atrial tachycardia remains incompletely understood.

197 (control, n=16) and 3 canine AF-models: (1) atrial tachycardia remodeling (ATR; n=16) induced by atr

198 0.10.1+/-0.00.5+/-0.40.3+/-0.1 ATR indicates atrial tachycardia remodeling; CAF, chronic atrial fibri

199 Atrial tachycardia requiring RFCA deep within the CS has

200 Modeling of macroreentrant atrial tachycardia revealed that reentry on closed surfa

201 schemes of atrial flutter and macroreentrant atrial tachycardias, reviews the technique of radiofrequ

202 = 43), 3) atrial tachycardia (n = 19) and 4) atrial tachycardia simulated by demand atrial pacing in

203 (n=78/102, 76%), atrial flutter (8/102, 8%), atrial tachycardia/supraventricular tachycardia (n=9/102

204 topic beats triggering AF or sustained focal atrial tachycardia that occurred spontaneously, after AF

205 0 (28%) of 35 consecutive patients with left atrial tachycardia, the arrhythmia originated from the M

206 ntribute to the positive inotropy and sinus (atrial) tachycardia traditionally attributed to chronic,

207 flutter, atrioventricular nodal reentry, and atrial tachycardia, treated with conventional ablation (

208 es including hypertrophic cardiomyopathy and atrial tachycardia, tumor predisposition, and cognitive

209 ented with paroxysmal atrial fibrillation or atrial tachycardia underwent preablation LGE CMR.

210 ibrillation, occurrence of atrial flutter or atrial tachycardia, use of antiarrhythmic drugs, or repe

211 e highest accuracy in algorithmic mapping of atrial tachycardia/ventricular tachycardia.

212 ltiple procedures, freedom from recurrent AF/atrial tachycardia was achieved in 87%.

213 Incisional atrial tachycardia was excluded in the remaining patient

214 Macro-reentrant atrial tachycardia was seen in 7 patients, and isthmus-d

215 verall, the rate of recurrent arrhythmia (AF/atrial tachycardia) was 21% at 1 year, 11% between 1 and

216 In patients with left atrial tachycardia, we investigated whether this region

217 Paroxysmal atrial fibrillation and atrial tachycardia were invariably (100%) preceded (<5 s

218 Focal atrial tachycardias were ablated with point lesions that

219 nty-three consecutive patients with 27 right atrial tachycardias were included in the study.

220 Twenty-three left-sided atrial tachycardias were mapped in 15 patients (age: 64+

221 Burst ventricular pacing excluded atrial tachycardia when the tachycardia terminated witho

222 aroxysmal atrial fibrillation and paroxysmal atrial tachycardia, which suggests that simultaneous sym

223 Five patients were documented to have focal atrial tachycardia, which was mapped to the coronary sin

224 from atrial fibrillation, atrial flutter, or atrial tachycardia while not receiving antiarrhythmic me